2023 Updates on Enhanced Recovery after Surgery protocols for plastic surgery of the breast and future directions
Perioperative pain control is an important component of any plastic surgery practice. Due to the incorporation of Enhanced Recovery after Surgery (ERAS) protocols, reported pain level, opioid consumption, and hospital length of stay numbers have decreased significantly. This article provides an up-to-date review of current ERAS protocols in use, reviews individual aspects of ERAS protocols, and discusses future directions for the continual improvement of ERAS protocols and control of postoperative pain.
Category
  • BUMC Proceedings
Format
  • Journal
Credits
  • 1.00 American Board of Internal Medicine (ABIM) MOC Part 2
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
2023 Optimal Cardiovascular Medical Therapy: Current Guidelines and New Developments
Coronary artery disease is a leading cause of mortality worldwide, and patients with obstructive coronary artery disease require optimal cardiovascular medical therapy along with lifestyle modification for secondary prevention of future cardiac events. Optimal medical therapy includes antiplatelet agents, high-intensity statins, beta-blockers, angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers, aldosterone antagonists, and calcium channel blockers. There are differences in the medical therapy guidelines of the American Heart Association/American College of Cardiology and the European Society of Cardiology. In addition, there are emerging medical therapies that may be added to future guidelines with additional cardiovascular outcome benefits.
Category
  • BUMC Proceedings
Format
  • Journal
Credits
  • 1.00 American Board of Internal Medicine (ABIM) MOC Part 2
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
2023 Management dilemmas in restarting anticoagulation after gastrointestinal bleeding
Systemic anticoagulants are widely prescribed to prevent and treat thromboembolism, among other indications. A common com-plication of using these agents is gastrointestinal bleeding. While early resumption of anticoagulants after the bleeding has resolved can increase the risk of rebleeding, delayed resumption puts the patient at increased risk of thromboembolic events and mortality. There is limited data on this topic to guide clinicians on resuming anticoagulation after hospitalization for gastrointestinal bleeding and to educate patients regarding the subsequent risks of recurrent gastrointestinal bleeding, thromboembolism, and mortality. The optimal time to resume anticoagulation is also unknown. This review summarizes the existing literature and available data on the commonly encountered dilemma of restarting anticoagulation therapy after hospitalization for gastrointestinal bleeding.
Category
  • BUMC Proceedings
Format
  • Journal
Credits
  • 1.00 American Board of Internal Medicine (ABIM) MOC Part 2
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
2023 Fall Pediatric Subspecialty for the Primary Care Provider
This activity is designed to provide the primary care provider with practical clinical information on the recognition and evaluation of specific pediatric subspecialty disorders seen frequently in primary care office settings. 
Category
  • Pediatrics
Format
  • Webinar live
  • Conference / meeting
Credits
  • 4.00 American Board of Pediatrics (ABP) MOC
  • 4.00 AMA PRA Category 1 Credit™
  • 4.00 Attendance
Event date October 6, 2023
2023 Women Leaders in Medicine: Fall Basecamp
You are engaging with an amazing group of women physician leaders and positively impacting the culture of healthcare at BSWH and beyond! Thank you for being part of our important efforts as an organization for the female physician.
Category
  • BSWH Members Only
Format
  • Conference / meeting
Credits
Event date October 19, 2023

Pages